In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 9th, 2004 | 16 | Yes |
Popular Name: Moxonidine Moxonidine
Find On: PubMed — Wikipedia — Google
CAS Numbers: , 75438-57-2 , 75438-57-2; 75438-58-3; 75536-04-8 , 75438-58-3 , 75536-04-8 , [75438-57-2] , [75438-58-3] , [75536-04-8]
4-chloro-N-imidazolidin-2-ylidene-6-methoxy-2-methylpyrimidin-5-amine
5-pyrimidinamine, 4-chloro-N-2-imidazolidinylidene-6-methoxy-2-methyl-
75438-57-2; C07451; Moxonidine
75438-57-2; Cynt (TN); D05087; Moxonidine (USAN/INN)
CPD000469209; MOXONIDINE HCl; SAM001246764
CPD000469209; MOXONIDINE HCl; SAM001246764; moxonidine
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -0.05 | 1.47 | -9.31 | 2 | 6 | 0 | 71 | 241.682 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Purity | 98.5% | APIChem |
Indications | antihypertensive | KeyOrganics Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP06645m; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
Target | Others | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP06645m; SALT: 1 hydrogen chloride | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA2A-2-E | Alpha-2a Adrenergic Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 150 | 0.60 | Binding ≤ 10μM |
ADA2B-3-E | Alpha-2b Adrenergic Receptor (cluster #3 Of 4), Eukaryotic | Eukaryotes | 1000 | 0.53 | Binding ≤ 10μM |
ADA2C-2-E | Alpha-2c Adrenergic Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 2000 | 0.50 | Binding ≤ 10μM |
NISCH-1-E | Nischarin (cluster #1 Of 4), Eukaryotic | Eukaryotes | 56 | 0.63 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 150 | 0.60 | Binding ≤ 1μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 1000 | 0.53 | Binding ≤ 1μM |
NISCH_HUMAN | Q9Y2I1 | Nischarin, Human | 4.19758984 | 0.73 | Binding ≤ 1μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 150 | 0.60 | Binding ≤ 10μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 1000 | 0.53 | Binding ≤ 10μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 2000 | 0.50 | Binding ≤ 10μM |
NISCH_HUMAN | Q9Y2I1 | Nischarin, Human | 4.19758984 | 0.73 | Binding ≤ 10μM |
Description | Species |
---|---|
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
G alpha (i) signalling events | |
G alpha (z) signalling events |